Recombinant Vaccinia virus Virion membrane protein A16 (A16L)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Vaccinia Virus Virion Membrane Protein A16 (A16L)

Recombinant Vaccinia virus Virion membrane protein A16 (A16L) is a protein derived from the Vaccinia virus, a member of the poxvirus family. This protein is encoded by the A16L open reading frame and plays a crucial role in the viral life cycle, particularly in virus entry and cell-cell fusion. The recombinant form of this protein is produced through genetic engineering techniques, often in bacterial systems like Escherichia coli, and is used for research purposes.

Structure and Characteristics of A16L

The A16L protein is a 378-amino-acid polypeptide with a predicted C-terminal transmembrane domain and 20 invariant cysteine residues. These cysteine residues form disulfide bonds via the poxvirus cytoplasmic redox system, which are essential for the protein's function . The protein is myristylated at a conserved glycine near the N-terminus, which may influence its membrane association . The A16L protein is expressed late in the viral infection cycle and is incorporated into intracellular mature virions, with its N-terminal segment exposed on the surface .

Role in Virus Life Cycle

A16L is essential for the entry of Vaccinia virus into host cells and for cell-cell fusion, a process critical for viral spread. Virions lacking A16L can bind to cells but fail to penetrate the cytoplasm and induce low-pH-triggered syncytium formation . This indicates that A16L, along with other proteins like A21, A28, H2, and L5, is crucial for viral entry and fusion mechanisms .

Recombinant Production

Recombinant A16L protein is typically produced in E. coli and is available as a full-length protein with a His-tag for purification purposes. The recombinant protein spans amino acids 2-378 and is often provided as a lyophilized powder with a purity of over 90% as determined by SDS-PAGE .

Applications and Research Findings

The recombinant A16L protein is primarily used in research to study the mechanisms of viral entry and cell-cell fusion. It can be applied in SDS-PAGE for protein analysis and is useful for understanding the role of A16L in the viral life cycle. Studies using recombinant viruses with inducible A16L expression have shown that A16L is crucial for maintaining viral infectivity and for the efficient replication of Vaccinia virus .

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
A16L; Virion membrane protein A16
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
2-378
Protein Length
Full Length of Mature Protein
Species
Vaccinia virus (strain Copenhagen) (VACV)
Target Names
A16L
Target Protein Sequence
GAAVTLNRIKIAPGIADIRDKYMELGFNYPEYNRAVKFAEESYTYYYETSPGEIKPKFCL IDGMSIDHCSSFIVPEFAKQYVLIHGEPCSSFKFRPGSLIYYQNEVTPEYIKDLKHATDY IASGQRCHFIKKDYLLGDSDSVAKCCSKTNTKHCPKIFNNNYKTEHCDDFMTGFCRNDPG NPNCLEWLRAKRKPAMSTYSDICSKHMDARYCSEFIRIIRPDYFTFGDTALYVFCNDHKG NRNCWCANYPKSNSGDKYLGPRVCWLHECTDESRDRKWLYYNQDVQRTRCKYVGCTINVN SLALKNSQAELTSNCTRTTSAVGDVHHPGEPVVKDKIKLPTWLGAAITLVVISVIFYFIS IYSRPKIKTNDINVRRR
Uniprot No.

Target Background

Function
The envelope protein of the entry-fusion complex, A16L, mediates viral membrane fusion with the host cell membrane during viral entry. It also plays a crucial role in cell-cell fusion (syncytium formation).
Protein Families
Poxviridae A16/G9/J5 family
Subcellular Location
Virion membrane; Single-pass type II membrane protein.

Q&A

What is the basic structure and location of the A16 protein in Vaccinia virus?

The A16 protein is a 378-amino-acid protein with a predicted C-terminal transmembrane domain and 20 invariant cysteine residues that are conserved across all sequenced members of the poxvirus family . It is expressed late during the infection cycle and becomes incorporated into intracellular virus particles . The protein is positioned such that its N-terminal segment is exposed on the surface of the virus particle, while the C-terminal portion anchors it within the viral membrane . The cysteine residues form disulfide bonds through the poxvirus cytoplasmic redox system, contributing to the protein's structural stability and functional capacity .

Why is the A16 protein considered essential for Vaccinia virus replication?

Researchers have determined the A16 protein's essential nature through unsuccessful attempts to isolate mutant viruses with the A16L gene deleted . To circumvent this limitation, scientists developed a recombinant Vaccinia virus incorporating the Escherichia coli lac operator system to regulate A16L gene transcription . Under conditions where A16 synthesis was repressed, both plaque size and virus yield were dramatically reduced (60-100 fold lower specific infectivity), definitively demonstrating its crucial role in the virus lifecycle . Despite this reduced infectivity, virus morphogenesis still proceeded and normal-appearing particles formed, indicating that A16's essential function relates specifically to infectivity rather than virus assembly .

How does the A16 protein function in viral entry mechanisms?

The A16 protein plays a critical role in the entry phase of the viral lifecycle. A16-deficient virions can successfully bind to host cells, but their cores cannot penetrate into the cytoplasm, effectively halting the infection process at the entry stage . Additionally, these A16-deficient virions are unable to induce low-pH-triggered syncytium formation, a process that normally facilitates viral spread . The protein appears to work in concert with at least four other conserved viral membrane proteins (A21, A28, H2, and L5) to enable both poxvirus entry into cells and cell-cell fusion mechanisms . This coordinated protein complex likely mediates the fusion of viral and cellular membranes required for core delivery into the cytoplasm.

How do the disulfide bonds in A16 protein affect its function in membrane fusion?

The 20 invariant cysteine residues in the A16 protein form disulfide bonds via the poxvirus cytoplasmic redox system, creating a specific tertiary structure critical for function . While the presence of these bonds has been established, their precise arrangement and contribution to functional domains remains an active area of investigation. The extensive disulfide bonding suggests the protein may undergo conformational changes during the fusion process, potentially exposing hidden domains that interact with cellular receptors or other viral proteins. Methodologically, researchers can employ site-directed mutagenesis to systematically substitute cysteine residues and assess the impact on fusion capability through syncytium formation assays. Alternatively, structural studies using hydrogen-deuterium exchange mass spectrometry can map these disulfide bonds and their dynamics during fusion events.

What is the relationship between A16 and the other four membrane proteins required for viral entry?

The A16 protein functions within a complex system involving at least four other conserved viral proteins: A21, A28, H2, and L5 . Experiments with inducible mutants of each protein reveal remarkably similar phenotypes, suggesting they operate as a functional complex or along a common pathway . To investigate these relationships, researchers can employ co-immunoprecipitation studies followed by cross-linking mass spectrometry to map interaction interfaces. Temporal studies using synchronous infection models with fluorescently tagged proteins can determine the sequence of recruitment during entry. Additionally, cryo-electron microscopy of the entry complex can provide structural insights into how these proteins assemble. Understanding this protein network is crucial for developing targeted antiviral strategies against poxviruses.

How does the N-terminal surface exposure of A16 contribute to host cell recognition?

The A16 protein's N-terminal segment is exposed on the virion surface, positioning it as a candidate for host cell interaction . This exposure pattern suggests potential roles in receptor recognition or initial membrane contact. Research approaches to address this question include developing monoclonal antibodies against different epitopes of the N-terminal domain to test for inhibition of viral entry. Complementary techniques involve creating truncation mutants of the N-terminal region and assessing their impact on host range and binding affinities. Biophysical methods such as biolayer interferometry can quantify binding kinetics between the isolated N-terminal domain and potential cellular receptors, providing insights into the initial steps of viral attachment and subsequent fusion events.

What experimental design is most appropriate for studying A16 protein function in different cell types?

When investigating A16 protein function across different cell types, a true experimental design incorporating multiple control groups is essential. The Solomon four-group design would be particularly effective, as it controls for both testing effects and treatment effects . This design involves:

GroupPretestTreatmentPosttest
1 (R)OX (A16+)O
2 (R)O-O
3 (R)-X (A16+)O
4 (R)--O

Where R indicates randomization, O represents observation/measurement, and X represents the experimental condition (cells infected with virions containing A16) . This approach allows researchers to:

  • Assess baseline differences between cell types before infection

  • Control for potential sensitization effects from pretesting

  • Isolate the specific effects of A16 presence across different cell lineages

  • Reduce threats to both internal and external validity

For cell-type dependent studies, each group should contain representatives of multiple cell lineages to determine if A16 requirements vary across tissue origins.

How should researchers design experiments to differentiate between A16's role in binding versus penetration?

To differentiate between A16's functions in binding versus penetration, a posttest-only control group design with multiple measurement points is recommended . This approach requires:

  • Creating recombinant viruses with inducible A16L expression

  • Establishing randomized treatment groups exposed to virions with and without A16

  • Implementing a temporal series of measurements tracking:

    • Initial virion binding (using fluorescently labeled particles)

    • Membrane fusion events (through lipid mixing assays)

    • Core entry (via detection of viral cores in cytoplasm)

    • Early gene expression (as confirmation of successful entry)

Statistical analysis should employ repeated measures ANOVA to identify precisely where the infection process is interrupted in the absence of A16. This design eliminates pre-test sensitization concerns while still providing robust evidence for the stage-specific function of A16 in the viral entry process.

What controls are necessary when conducting complementation studies with A16 mutants?

Complementation studies with A16 mutants require a pretest-posttest control group design with additional validity safeguards . Key methodological considerations include:

Control TypePurposeImplementation
Negative controlsEstablish baselineCells with empty vectors lacking A16 sequences
Positive controlsVerify system functionalityWild-type A16 expression constructs
Dosage controlsAccount for expression levelsTitration series of expression vectors
Temporal controlsAddress timing effectsInducible expression at different infection stages
Specificity controlsRule out non-specific effectsExpression of irrelevant membrane proteins

When testing multiple A16 mutants, Latin square designs can efficiently control for positional effects and inter-assay variability . This approach ensures that observed phenotypes can be confidently attributed to specific mutations rather than experimental artifacts or expression differences.

How can researchers resolve contradictory findings regarding A16 protein interactions?

When facing contradictory findings about A16 protein interactions, researchers should implement a structured contradiction analysis framework. Using the (α, β, θ) notation system, where α represents the number of interdependent items (potential interaction partners), β represents the number of contradictory dependencies identified, and θ represents the minimal number of Boolean rules needed to assess these contradictions .

For example, if five studies report different A16 interaction partners with contradictory results, this might represent a (5,7,3) pattern – five proteins with seven contradictory interaction reports that can be resolved with three Boolean rules. Resolution steps include:

  • Systematically cataloging all reported interactions and their experimental conditions

  • Identifying pattern dependencies (e.g., cell-type specific, pH-dependent, or conformation-specific interactions)

  • Applying Boolean minimization to determine the minimal set of conditions explaining the contradictions

  • Designing targeted experiments to test the derived Boolean rules

This structured approach transforms seemingly contradictory findings into a more complex but coherent understanding of context-dependent protein interactions.

What statistical approaches are most appropriate for analyzing A16 mutant phenotypes?

When analyzing A16 mutant phenotypes, researchers must consider the multidimensional nature of the data. Rather than simple binary comparisons, a hierarchical statistical approach is recommended:

  • First, employ multivariate analysis of variance (MANOVA) to determine if mutants differ significantly from wild-type across all measured parameters

  • Follow with discriminant function analysis to identify which specific measurements most strongly differentiate between mutant groups

  • For specific comparisons, use Bonferroni-corrected t-tests or non-parametric alternatives based on data distribution

  • Implement dimension reduction techniques like principal component analysis to visualize clustering of mutant phenotypes

For time-series data (such as entry kinetics), mixed-effects models better account for both fixed effects (mutation type) and random effects (experimental variation). This comprehensive approach prevents both Type I errors from multiple comparisons and oversimplification of complex phenotypic changes.

How can researchers integrate contradictory data from different experimental systems studying A16 function?

Integrating data from diverse experimental systems requires recognizing that contradictions often reflect real biological complexity rather than experimental error. A structured approach includes:

  • Characterizing data sets using the (α, β, θ) framework to define the scope of contradiction

  • Developing a standardized metadata schema documenting key experimental variables:

    • Cell types and their passage numbers

    • Viral strains and preparation methods

    • Buffer compositions and pH values

    • Temperature and timing parameters

    • Detection methods and their sensitivities

  • Applying Boolean logic to define conditional rules explaining when each observation holds true

  • Creating an integrated model that incorporates conditional dependencies

This approach transforms apparent contradictions into a more nuanced understanding of A16 function across different contexts. The goal is not to determine which experiment is "correct," but rather to define the boundary conditions within which each observation is valid.

What are the most promising approaches for determining the three-dimensional structure of the A16 protein?

Given the challenges of crystallizing membrane proteins like A16, researchers should pursue multiple complementary structural biology approaches:

  • Cryo-electron microscopy (cryo-EM) of purified A16 in nanodiscs or detergent micelles, potentially achieving 3-4Å resolution

  • Nuclear magnetic resonance (NMR) studies of individual domains, particularly the soluble N-terminal region

  • Cross-linking mass spectrometry to identify proximity relationships between protein segments

  • Hydrogen-deuterium exchange mass spectrometry to map solvent-accessible regions and conformational dynamics

  • Computational approaches combining AlphaFold2 predictions with experimental constraints

The membrane-associated nature of A16 presents specific challenges, but recent advances in computational approaches combined with limited experimental data hold promise for resolving its structure. Understanding the three-dimensional arrangement of the 20 conserved cysteine residues would provide critical insights into function and potential targeting strategies.

How might CRISPR-Cas9 genome editing advance understanding of host factors required for A16-mediated entry?

CRISPR-Cas9 screening offers unprecedented opportunities to identify host factors interacting with the A16 protein during viral entry. A comprehensive research program would include:

  • Genome-wide CRISPR knockout screens in permissive cell lines, selecting for resistance to Vaccinia infection

  • Focused CRISPR activation/inhibition libraries targeting membrane proteins and fusion regulators

  • Domain-specific screens using CRISPR base editing to introduce subtle mutations in candidate receptors

  • Time-resolved screens capturing factors involved at different stages of the entry process

Data analysis should employ computational approaches that identify both individual hits and pathway enrichment. Validation would require generating specific knockout cell lines and complementing with wild-type expression constructs. This systematic approach could identify novel host factors that specifically interact with A16 during the entry process, potentially revealing new antiviral targets.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.